[HTML][HTML] COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …
[HTML][HTML] Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta …
Background Hydroxychloroquine or chloroquine with or without azithromycin have been
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
widely promoted to treat coronavirus disease 2019 (COVID-19) following early in vitro …
[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Substantial COVID-19 research investment has been allocated to randomized clinical trials
(RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
(RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
Association between caseload surge and COVID-19 survival in 558 US hospitals, March to August 2020
Background: Several US hospitals had surges in COVID-19 caseload, but their effect on
COVID-19 survival rates remains unclear, especially independent of temporal changes in …
COVID-19 survival rates remains unclear, especially independent of temporal changes in …
Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19
Background The coronavirus disease 2019 (COVID‐19) pandemic has resulted in
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
substantial mortality. Some specialists proposed chloroquine (CQ) and hydroxychloroquine …
[HTML][HTML] Methodological quality of COVID-19 clinical research
The COVID-19 pandemic began in early 2020 with major health consequences. While a
need to disseminate information to the medical community and general public was …
need to disseminate information to the medical community and general public was …
[HTML][HTML] Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study
HM Dabbous, S Abd-Elsalam, MH El-Sayed… - Archives of …, 2021 - Springer
No specific antiviral drugs have been approved for the treatment of COVID-19. This study
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
aimed to evaluate the efficacy of favipiravir in treatment of COVID-19. This was a multicenter …
Combating oxidative stress and inflammation in COVID‐19 by molecular hydrogen therapy: mechanisms and perspectives
D Alwazeer, FFC Liu, XY Wu… - Oxidative Medicine and …, 2021 - Wiley Online Library
COVID‐19 is a widespread global pandemic with nearly 185 million confirmed cases and
about four million deaths. It is caused by an infection with the severe acute respiratory …
about four million deaths. It is caused by an infection with the severe acute respiratory …
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Z Kashour, M Riaz, MA Garbati… - Journal of …, 2021 - academic.oup.com
Objectives Clinical studies of chloroquine (CQ) and hydroxychloroquine (HCQ) in COVID-19
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …
Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: a randomized clinical trial
BS Abella, EL Jolkovsky, BT Biney… - JAMA internal …, 2021 - jamanetwork.com
Importance Health care workers (HCWs) caring for patients with coronavirus disease 2019
(COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 …
(COVID-19) are at risk of exposure to severe acute respiratory syndrome coronavirus 2 …